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Abstract We have isolated a potent platelet aggregation
inducer from the crude venom of Calloselasma rhodostoma
(Malayan pit viper), termed rhodoaggretin, with a novel
oligomeric structure consisting of a dimer of C-type lectin-like
heterodimers. On the basis of its native molecular mass of 66
kDa, and a Mr of 30 kDa for its disulfide-linked KL-heterodimer,
we propose that rhodoaggretin exists as a (KL)2 complex in the
native state. We postulate that the di-dimer is stabilized by non-
covalent interactions as well as by an intersubunit disulfide bridge
between the two KL-heterodimers. This conclusion is based on the
following observations: (a) sodium dodecylsulfate^polyacryl-
amide gel electrophoresis (SDS^PAGE) of the non-reduced
rhodoaggretin gave a major 28 and a minor 52 kDa band. (b)
Prior treatment of rhodoaggretin with a limited amount of 2-
mercaptoethanol (2-ME; 0.1%) resulted in the complete abol-
ishment of the 52 kDa band in SDS^PAGE. (c) Two-dimensional
SDS^PAGE in the presence of 3% 2-ME showed that both the
28 and 52 kDa bands gave two bands each with Mrs of 18 (K-
subunit) and 15 (L-subunit) kDa. (d) Mass spectrometric
analyses showed that purified rhodoaggretin had a Mr of
30 155.39 þ 3.25 Da while its s-pyridylethylated K- and L-
subunits had Mrs of 16 535.62 þ 2.98 and 15 209.89 þ 1.61 Da
respectively. These molecular weight data suggested the presence
of 15 cysteinyl residues in rhodoaggretin as compared to the 14
that are reported for the heterodimeric C-type lectin-like
proteins. This extra cysteinyl residue is a candidate for the
formation of the intersubunit disulfide bond in the (KL)2 complex.
(e) Homology structural modeling studies showed that the extra
cysteinyl residue can indeed form a disulfide bond that covalently
links the two KL-heterodimers as proposed above. ß 2001 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
C-type lectin-like proteins (CLPs) are a group of snake
venom proteins that are structurally homologous to the car-
bohydrate recognition domain of animal C-type lectins [1^10].
Most of these proteins exist as KL-heterodimers linked by a
single interchain disul¢de bond, with molecular masses of
V30 kDa. Despite their striking structural similarity, this
group of proteins have di¡erent e¡ects on blood coagulation
and platelet aggregation. Some of these proteins exhibit anti-
coagulant activities by binding to the coagulant factors X and/
or IX [2^4], whereas other CLPs induce varied e¡ects on
platelet functions by modulating the interactions between
von Willebrand factor (vWF) and platelet glycoprotein Ib
(GPIb) [5^9].
Recently, several higher molecular weight multimers of
CLPs with di¡erent e¡ects on platelet aggregation have also
been reported [7,10^13]. These proteins possess native molec-
ular masses of V50^150 kDa, suggesting that they may rep-
resent the dimeric, trimeric or tetrameric forms respectively of
the common V30 kDa disul¢de-linked KL-heterodimers of
CLPs. For example, convulxin from the South American rat-
tlesnake Crotalus durissus teri¢cus is a 72 kDa protein that
may exist as an (KL)3 complex [11]. Furthermore, in marked
contrast to other CLPs that act on platelets by modulating the
interactions between vWF and GPIb, convulxin was reported
to induce platelet aggregation via the GPVI collagen receptor
[14,15]. Similarly, the 50 kDa alboaggregin A (AL-A) was
found to potently induce platelet aggregation of platelet-rich
plasma (PRP) [12]. On the other hand, £avocetin (FL)-A and
-B from the venom of Trimeresurus £avoviridis, with native
molecular masses of 149 and 139 kDa respectively, inhibit
platelet aggregation at high shear stress [13]. The crystal struc-
ture of FL-A has just been published [16]. It is a novel cyclic
tetramer (KL)4 stabilized by interchain disul¢de bonds be-
tween heterodimers [16]. It was further concluded that the
high a⁄nity of FL-A for the platelet GPIb K-subunit could
be explained by a cooperative binding action through the
multiple binding sites of the tetramer [16].
In the present study, we propose a model for the three-
dimensional structure of rhodoaggretin, a potent platelet ag-
gregation inducer isolated from the venom of Calloselasma
rhodostoma (Malayan pit viper). It is shown to exist as a novel
di-dimeric (KL)2 complex in the native state, which is held
together by a combination of non-covalent interactions and
an intersubunit disul¢de linkage. We also provide experimen-
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tal evidence to show that rhodoaggretin is the same protein as
aggretin [17,18] and rhodocytin [19].
2. Materials and methods
2.1. Materials
Crude venom of C. rhodostoma was purchased from Sigma Chem-
ical Co. (St. Louis, MO, USA). Fast protein liquid chromatography
(FPLC) and high performance liquid chromatography (HPLC) col-
umns were from Amersham-Pharmacia Biotech and Vydac respec-
tively, and peptide sequencing chemicals/reagents were from PE-
ABD (Foster City, CA, USA). All bu¡er salts and organic solvents
were from standard commercial sources and of the highest quality
available.
2.2. Puri¢cation of rhodoaggretin
C. rhodostoma crude venom (100 mg) was dissolved in 3.0 ml of
0.1 M ammonium hydrogen carbonate (pH 8.0) and centrifuged at
12 000Ug for 10 min at 4‡C to remove particulate material. The
supernatant was then fractionated by a HiLoad Superdex 75 column
(2.6U60 cm) equilibrated with the same bu¡er using a FPLC system.
The fractions from peak I (containing proteins of interest based on
platelet assays) were pooled and loaded directly onto a Mono Q HR
5/5 column pre-equilibrated with 20 mM Tris^HCl, pH 8.2. Elution
was performed with a linear gradient of 0^0.5 M NaCl in 20 mM
Tris^HCl bu¡er, pH 8.2 over 30 min.
2.3. Separation of subunits
Puri¢ed rhodoaggretin was reduced and s-pyridylethylated (s-PE)
based on the method of Wang et al. [1]. The K- and L-subunits were
subsequently separated by reverse-phase HPLC (RP-HPLC) using a
pH stable C8 Vydac column (4.1U250 mm).
2.4. Molecular weight determination
Molecular weights of the native protein and its subunits were de-
termined by gel ¢ltration, sodium dodecylsulfate^polyacrylamide gel
electrophoresis (SDS^PAGE) and electrospray ionization^mass spec-
trometry (ESI^MS).
(A) Gel ¢ltration. The native molecular weight of rhodoaggretin
was estimated by gel ¢ltration chromatography on a Superose 12
HR 10/30 column using a FPLC system. The column was equilibrated
and eluted with 0.1 M ammonium hydrogen carbonate at a £ow rate
of 0.3 ml/min. Molecular weight standard proteins used included glu-
tamate dehydrogenase (290 000), lactate dehydrogenase (142 000), eno-
lase (67 000), adenylate kinase (32 000) and cytochrome c (12 400)
(Oriental Yeast Company, Japan).
(B) SDS^PAGE. Non-reducing and reducing (in the presence of 5%
2-mercaptoethanol (2-ME)) SDS^PAGE were performed in 12.5% gel
as described previously [20]. For limited reduction of rhodoaggretin,
Fig. 1. Puri¢cation of rhodoaggretin. A: Gel ¢ltration chromatogra-
phy of C. rhodostoma crude venom on a HiLoad 26/60 Superdex 75
column. Elution was performed at 2 ml/min. B: Anion exchange
chromatography on a Mono Q HR 5/5 column. Fractions from the
peak I of gel ¢ltration were directly applied to a Mono Q HR 5/5
column that had been equilibrated with 20 mM Tris^HCl bu¡er,
pH 8.2. The protein was eluted at a £ow rate of 1 ml/min with a
linear gradient of 0^0.5 M NaCl in 20 mM Tris^HCl bu¡er, pH 8.2
over 30 min. C: Separation of s-PE rhodoaggretin K- and L-chains
by RP-HPLC on a C8 Vydac column (4.6U250 mm). Solvent A,
0.1% (v/v) tri£uoroacetic acid; B, 0.085% (v/v) tri£uoroacetic acid
in 70% (v/v) acetonitrile.
Fig. 2. A: Determination of the native molecular weight of rho-
doaggretin. Gel ¢ltration chromatography of standard proteins and
puri¢ed rhodoaggretin was carried out as described in Section 2.
The standard curve was constructed using the molecular weights of
standard proteins versus their Ve/Vo values. B: Elution pro¢le of
rhodoaggretin and rhodocetin on the same FPLC column.
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di¡erent ¢nal concentrations (0.03, 0.1, and 0.3%) of 2-ME were
added to treat the samples before electrophoresis.
(C) Two-dimensional (2D) SDS^PAGE. One-dimensional non-re-
ducing SDS^PAGE was performed as in (B). After electrophoresis,
one lane was excised from the unstained gel, and incubated in SDS
sample bu¡er containing 3% 2-ME for 0.5 h. This treated gel strip was
then transferred to the top of a second 12.5% SDS gel before electro-
phoresis in the second dimension.
(D) ESI^MS. MS was carried out using a Perkin-Elmer Sciex API
300 LC/MS/MS system, a triple-stage quadruple instrument equipped
with an ionspray interface. The ionspray voltage was set to 4000 V,
ori¢ce voltage at 75 V, and the interface temperature at 60‡C. Nitro-
gen was used as a curtain gas with a £ow rate of 0.6 l/min, and as a
nebulizer gas at 30 psi. A Shimadzu LC-10AD series pump system
was used for solvent delivery.
2.5. Determination of the isoelectric point
The isoelectric point of rhodoaggretin was determined using aga-
rose IEF in a pH range of 3^10 (Pharmalyte) based on the manufac-
turer’s protocol.
2.6. Determination of N-terminal amino acid sequence
The N-terminal amino acid sequences of the K- and L-subunits of s-
PE rhodoaggretin were determined by automated Edman degradation
using an Applied Biosystems 477A pulsed liquid-phase sequencer
equipped with an on-line PTH amino acid analyzer (120A).
2.7. Platelet aggregation
Blood drawn from the central arteries of rabbit ears was anticoag-
ulated with 0.11 M tri-sodium citrate (1:9, v/v). PRP was obtained
by centrifugation of the blood for 20 min at 375Ug and 20‡C.
Washed platelets were prepared as described previously [21]. Platelet
aggregation in whole blood was measured by the impedance method
[22], using a Chronolog Model 500-CA whole blood aggregometer
(Chronolog, Havertown, PA, USA), under continuous stirring at
1000 rpm. Platelet aggregation in PRP and washed platelets, on the
other hand, were monitored by light transmission [23].
2.8. Peptide mapping
The s-PE K- and L-subunits of rhodoaggretin were digested with
endoproteinase Lys-C and the peptides fractionated by RP-HPLC as
described earlier [1]. Selected peptides were analyzed by ESI^MS, as
detailed above.
2.9. Homology modeling
Homology structural modeling of aggretin (rhodoaggretin) was car-
ried out using the structure of coagulation factor (IX/X) binding
protein [24] as the target template. The LOOK modeling package
[25] was used to ¢rst construct a monomer of each of the molecules.
The ‘model homolog’ option was used so that the entire molecule
including loops could be modeled. This option also allowed modeling
of the loops using segment match modeling, which uses a database of
Fig. 3. A: SDS^PAGE of rhodoaggretin in the presence (R) and absence (NR) of 2-ME. B: SDS^PAGE in the absence (lane 1) and presence
of 0.1% 2-ME (lane 2). M.W., molecular weight markers. C: 2D SDS^PAGE of rhodoaggretin. The ¢rst dimension was carried out in the ab-
sence of 2-ME.
Fig. 4. ESI^MS spectra of the s-PE K- and L-subunits of rhodoag-
gretin and unmodi¢ed rhodoaggretin.
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highly re¢ned protein structures to ¢nd similar fragments to the target
structure that is being modeled and subsequently this model is sub-
jected to energy minimization [26]. The resulting structure was sub-
sequently loaded into the modeling package SYBYL 6.6 (Tripos Inc.,
MO, USA) and one or two copies of the molecule were made. Multi-
mers were then created manually by moving the molecules so that free
cysteinyls would be positioned close to each other allowing thus for
disul¢de formation.
3. Results
3.1. Puri¢cation of rhodoaggretin
The crude venom of C. rhodostoma was separated into ¢ve
main fractions by Superdex 75 gel ¢ltration chromatography
(Fig. 1A). Fraction I, which was found to induce platelet
aggregation potently in rabbit and human whole blood,
PRP and washed platelets, was thus subjected to further frac-
tionation on a Mono Q column. This puri¢cation step re-
sulted in three fractions (Fig. 1B) of which only fraction 3
exhibited marked aggregatory activity towards platelets. This
fraction was designated as rhodoaggretin. It is an acidic pro-
tein with an isoelectric point (pI) of 3.45.
3.2. Determination of the molecular weight of rhodoaggretin
The native molecular weight of rhodoaggretin was deter-
mined to be 66 000 by gel ¢ltration chromatography on a
Superose 12 column (Fig. 2A). In a separate experiment, the
relative elution volumes for rhodoaggretin and rhodocetin are
compared (Fig. 2B). On reducing SDS^PAGE, rhodoaggretin
exhibited two bands with molecular masses of 18 and 15 kDa
(designated as K- and L-subunits respectively) (Fig. 3A).
Under non-reducing conditions, however, two distinctive
bands with apparent molecular masses of 28 kDa and 52
kDa were observed (Fig. 3A). At a concentration of 0.1% 2-
ME, the 52 kDa band was abolished, and only the 28 kDa
band remained as the predominant component (Fig. 3B). This
suggested that the 52 kDa protein is an interdisul¢de-linked
dimer of the 28 kDa protein. This conclusion is supported by
the result of the 2D SDS^PAGE experiment which showed
Fig. 5. Comparison of the N-terminal amino acid sequences of rho-
doaggretin with those of CLPs from other snake venoms. The N-
terminal amino acid sequences of the K- and L-subunits of rhodoag-
gregin are compared with the CLPs isolated from other snake ven-
oms, including rhodocytin [19], aggretin [18], convulxin [11], FL-A
[16], rhodocetin [1], botrocetin [27], alboaggregin B [28], echicetin
[29], ECLV IX/X-bp [2], habu factor IX/X-bp [3], habu factor IX-
bp [4] and jararaca GPIb-bp [30].
Fig. 6. Peptide mapping of the s-PE (A) K- and (B) L-subunits of
rhodoaggretin after proteolytic digestion by endoproteinase Lys-C.
Table 1
Mass spectrometric analysis of K- and L-subunits and puri¢ed pep-
tides from endoproteinase Lys-C digestion of rhodoaggretin
Peptides Residue no.a Calculatedb Observedc
K-Subunit
Intact 1^136 16 531.83 16 534.43 þ 2.98
K16 112^117 721.43 721.70 þ 0.16
K54 118^132 2130.94 2 130.56 þ 0.18
K55 1^24 3 090.28 3 090.55 þ 0.98
K56 80^104 2 947.30 2 947.59 þ 0.91
K64 62^79 2 135.04 2 134.88 þ 0.37
K82 32^61 3 412.64 3 413.13 þ 0.74
L-Subunit
Intact 1^23 15 209.19 15 209.89 þ 1.61
K47 36^53 2 030.00 2 030.34 þ 0.26
K60 89^120 4 159.81 4 160.13 þ 0.18
K75 61^87 3 424.63 3 424.51 þ 1.75
aBased on aggretin sequence.
bMolecular masses calculated from the amino acid sequences of the
denoted peptides of aggretin.
cMolecular masses calculated from multiple charged signals ob-
served.
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that both the 52 and 28 kDa bands gave rise to 18 and 15 kDa
bands in the presence of excess (3%) 2-ME (Fig. 3C).
Puri¢ed rhodoaggretin, which eluted as a single peak in RP-
HPLC, gave a molecular mass of 30 155.39 þ 3.25 Da when
analyzed by ESI^MS (Fig. 4). The K- and L-subunits, after
reduction and pyridylethylation, were separated by RP-HPLC
(Fig. 1C), and their molecular masses as determined by ESI^
MS were 16 535.62 þ 2.98 and 15 209.89 þ 1.61 Da respectively
(Fig. 4).
3.3. N-terminal amino acid sequence analysis
The N-terminal amino acid sequences of the K- and L-sub-
units of rhodoaggretin were determined by sequencing the
individual reduced and s-PE subunits (Fig. 5). A high degree
of sequence identity was observed between the two subunits.
When aligned with those of other known members of the CLP
superfamily from snake venoms (Fig. 5), the K- and L-sub-
units of rhodoaggretin showed identical N-terminal sequences
with rhodocytin [19] and aggretin [18] and a relatively high
degree of sequence identity with rhodocetin [1], convulxin
[10,11], FL-A [16], botrocetin [27], alboaggregin B [28], echi-
cetin [29], ECLV IX/X-bp [2], habu IX/X-bp [3], habu IX-bp
[4] and jararaca GPIb-bp [30].
3.4. Peptide mapping studies
The peptide maps for the s-PE K- and L-subunits of rho-
doaggretin are shown in Fig. 6A,B respectively. The molecular
masses for the selected peptides as determined by ESI^MS are
summarized in Table 1. These peptide masses were compared
with the calculated masses for the corresponding peptides of
aggretin whose complete sequence was published recently [18].
Fig. 7 also showed the alignment of these peptides with the
complete amino acid sequences of the K- and L-subunits of
aggretin.
3.5. E¡ect of rhodoaggretin on platelet aggregation
Rhodoaggretin itself could induce platelet aggregation in
rabbit and human whole blood, PRP and washed platelets
with a lag period in an all-or-none manner (Fig. 8). For ex-
ample, at a concentration of 0.03 Wg/ml, it did not induce any
aggregation, but at 0.04 Wg/ml, it resulted in maximal aggre-
Fig. 7. A: The sequences of the Lys-C peptides of rhodoaggretin
(9) that matched the corresponding peptide sequences of aggretin
[18], based on the MS data (Table 1). B: The location of the intra-
and intermolecular disul¢de bridges of each rhodoaggretin (aggretin)
heterodimer, and the proposed disul¢de bond that is formed by
Cys115^Cys115 of the two L-chains of the di-dimer.
Fig. 8. Platelet aggregation induced by various concentrations of
rhodoaggretin. Various concentrations of rhodoaggretin (0.03^5.0
Wg/ml) were added to washed rabbit platelet suspension to induce
platelet aggregation. The arrows mark the addition of rhodoaggre-
tin. vT denotes the change in light transmission.
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gation (Fig. 8). Interestingly, the initial latent period of ag-
gregation was a direct function of protein concentration.
3.6. Molecular modeling studies
The aggretin (rhodoaggretin) model (Fig. 9) showed that it
contained three intracaternary disul¢de bonds within each of
the K- (Cys5^16, Cys33^131, Cys106^123) and L- (Cys2^13,
Cys30^119, Cys96^111) chains. Residues Cys75 from the L-
chain and Cys83 from the K-chain form the interdisul¢de
bond between these subunits. Most interestingly, the extra
cysteine residue (Cys115) from the L-chain of each aggretin
heterodimer can form a disul¢de bond with the L-chain of
another heterodimer, which thus stabilizes the 52 kDa dimer.
In addition, residues Leu112 and Trp56 from two dimer-re-
lated K-chains help to bridge the intermolecular contact region
with a hydrophobic area (Fig. 9).
4. Discussion
Based on the observations made in this study, we suggest
that rhodoaggretin, rhodocytin and aggretin are the same
protein found in the venom of C. rhodostoma. With the recent
publication of the complete sequence of aggretin [18] we were
able to con¢rm that rhodoaggretin is indeed the same protein
as aggretin by peptide mapping, and mass spectrometric anal-
yses. It was not clear why under non-reducing conditions
aggretin and rhodocytin were not shown earlier to contain
any bands with Mrs 50 000 [17,19]. In a recent paper, how-
ever, Navdaev et al. [31] reported that their aggretin prepara-
tion did contain 60 and 28 kDa bands under non-reducing
SDS^PAGE.
Several high molecular weight potent platelet agonists/an-
tagonists isolated from snake venoms have been identi¢ed as
CLP superfamily members [7,10^13,32]. These proteins usu-
ally possess molecular masses in excess of 50 kDa under non-
reducing conditions of SDS^PAGE, but upon reduction gave
rise to heterodimeric 12^15 kDa subunits with N-terminal
amino acid sequences that are highly homologous to the
CLPs. These proteins are also usually found in venoms that
already contained the well-characterized heterodimeric CLPs.
Hitherto, the quaternary structures of these multimeric CLPs
are not known, but with the recent publication of the crystal
structures of FL-A [16], factor IX/X-bp [24], factor IX-bp
[33], and botrocetin [34] it has become possible to predict
the structures of some of these proteins based on molecular
homology modeling studies. FL-A, with a Mr of 149 kDa, has
been shown to be a novel tetramer (KL)4 made up of four KL-
heterodimers related by a crystallographic four-fold symmetry
[16]. The tetramerization is mediated by an interchain disul-
¢de bridge between cysteinyl residues (CysK135) at the C-ter-
Fig. 9. A rendering of putative (rhodo)aggretin dimer using Molscript [35]. K-Subunits are colored in purple and green while their correspond-
ing L-subunits are colored in orange and crimson respectively. Residues Cys75 of the L-chain and Cys83 of the K-chain forming the interdisul-
¢de bond within the same heterodimer are labeled as A83^B75 and C83^D75 for the two independent dimers. Residues CysL115, LeuK112,
and TrpK56 are also labeled and show how they can stabilize the molecule by interacting with their dimer-related residues.
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minus of the K-subunit and at the N-terminus of the L-subunit
(CysL3) in the neighboring KL-heterodimer [16]. Therefore,
the additional cysteinyl residues in the K- and L-subunits of
each KL-heterodimer seem to hold the key to the formation of
this type of multimeric structure.
Our results here suggest that rhodoaggretin (aggretin, rho-
docytin), which has a native Mr of 60 kDa, is a dimer of the
KL-heterodimer. The stabilization of the dimer seems to in-
volve both an interdisul¢de bond and non-covalent interac-
tions between the KL-heterodimers. Firstly, we established
that there was an extra cysteinyl residue in rhodoaggretin
based on the MS results of the s-PE K- and L-subunits and
the unmodi¢ed KL-heterodimer. We found there were 15 in-
stead of the expected 14 cysteinyl residues that were reported
for all known KL-heterodimeric CLPs [2^9], except rhodocetin
[1]. This ¢nding was subsequently con¢rmed by the publica-
tion of the complete sequence of aggretin, in which an addi-
tional cysteinyl residue was located at position 115 in the L-
chain [18]. It could thus be postulated that CysL115 is a pos-
sible site for the dimerization of the KL-heterodimer via disul-
¢de formation between the L-chains of each heterodimer. Our
SDS^PAGE results under non-reducing conditions supported
this suggestion since the minor 52 kDa band could be re-
moved completely by 0.1% of 2-ME (Fig. 3B). However, the
major stabilizing force in the dimerization of the KL-hetero-
dimer is non-covalent in nature. Our structural modeling stud-
ies based on the published structure of factor IX/X-bp were in
full accord with this conclusion (Fig. 9). This conclusion is to
be contrasted with the result for AL-A, in which under non-
reducing SDS^PAGE, only a 52 kDa band was evident
[7,12,32], suggesting dimerization was mainly a result of inter-
disul¢de bond formation between the subunits. However, un-
like rhodoaggretin, AL-A was shown to consist of four di¡er-
ent polypeptide chains of 111^132 amino acids in length, and
Kowalska et al. [32] had proposed how the individual chains
are stabilized by inter- and intradisul¢de bonds. However,
there was no structural evidence to support their suggestion
[32].
In summary, we have isolated and characterized a di-dimer-
ic CLP with a novel degree of oligomerization. In contrast to
of FL-A [16] and CVX [11], where the tetrameric and trimeric
structures are held together in a ‘head-to-tail’ con¢guration by
disul¢de bonds respectively, the rhodoaggretin dimer is stabi-
lized mainly by non-covalent forces and a disul¢de bond be-
tween the two L-subunits probably via a ‘side-to-side’ inter-
action. Since the extra cysteinyl residue (CysL115) is not the
C-terminal amino acid, and hence not so £exible, we suggest
that the disul¢de bond formed between the L-subunits from
each KL-heterodimer is most probably a random process, thus
resulting only in a minor contribution to the stabilization of
the dimeric structure of rhodoaggretin.
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